Investigator Agreement Template for Australia

An Investigator Agreement is a fundamental legal contract that governs the relationship between research sponsors and medical professionals conducting clinical trials in Australia. This document establishes clear responsibilities, protects all parties' interests, and ensures compliance with strict Australian regulatory requirements while maintaining the highest standards of research integrity and participant safety.

When do you need this document?

You need an Investigator Agreement whenever initiating a clinical trial involving human participants in Australia. This includes pharmaceutical studies conducted by drug companies, medical device trials, investigational treatment research, and academic clinical studies. The agreement is required before any research activities begin, whether you're a pharmaceutical company engaging a hospital investigator, a CRO coordinating multi-site trials, or a university establishing research partnerships. It's also essential when sub-investigators join existing studies or when research scope changes significantly during the trial process.

Key legal considerations

Several critical legal elements must be carefully addressed in your Investigator Agreement. Compliance clauses must reference the Therapeutic Goods Act 1989, NHMRC guidelines, and applicable state health regulations. Data protection provisions must align with the Privacy Act 1988 and Australian Privacy Principles, particularly regarding participant health information. Intellectual property clauses should clearly define ownership of research discoveries under the Patents Act 1990. The agreement must include detailed protocol adherence requirements, adverse event reporting procedures, and participant safety obligations. Financial arrangements, including investigator payments and institutional overhead costs, require transparent documentation. Confidentiality provisions must protect proprietary research information while allowing necessary regulatory disclosures.

Legal requirements in Australia

Australian clinical trials operate under a comprehensive regulatory framework that your Investigator Agreement must address. The Therapeutic Goods Administration (TGA) requires compliance with Good Clinical Practice (GCP) guidelines and the Australian Code for the Responsible Conduct of Research. Ethics committee approval from properly constituted Human Research Ethics Committees (HRECs) is mandatory before trial commencement. The agreement must specify obligations under the Health Practitioner Regulation National Law for involved medical professionals. State-specific health department notifications may be required depending on your trial location. Contract law principles govern the enforceability of terms, making clear language and defined obligations essential. Insurance and indemnity provisions must meet Australian standards for clinical trial coverage. Regular monitoring and audit rights should be established to ensure ongoing compliance throughout the trial period.